{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:40:32Z","timestamp":1778539232910,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"instituto de salud carlos iii","doi-asserted-by":"publisher","award":["COV20\/00181"],"award-info":[{"award-number":["COV20\/00181"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"consejer\u00eda de sanidad, comunidad de madrid","doi-asserted-by":"publisher","award":["2020\/0082"],"award-info":[{"award-number":["2020\/0082"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10875-021-01174-5","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T12:09:48Z","timestamp":1637150988000},"page":"240-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7902-0527","authenticated-orcid":false,"given":"Daniel","family":"Arroyo-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9859-9012","authenticated-orcid":false,"given":"Oscar","family":"Cabrera-Marante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-1991","authenticated-orcid":false,"given":"Roc\u00edo","family":"Laguna-Goya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4362-1996","authenticated-orcid":false,"given":"Patricia","family":"Almendro-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1839-3853","authenticated-orcid":false,"given":"Octavio","family":"Carretero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6152-0080","authenticated-orcid":false,"given":"Francisco Javier","family":"Gil-Etayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1601-6464","authenticated-orcid":false,"given":"Patricia","family":"Su\u00e0rez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3026-7905","authenticated-orcid":false,"given":"Pilar","family":"P\u00e9rez-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7688-0495","authenticated-orcid":false,"given":"Edgard","family":"Rodr\u00edguez de Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1993-640X","authenticated-orcid":false,"given":"Antonio","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-8539","authenticated-orcid":false,"given":"Luis M.","family":"Allende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2211-9881","authenticated-orcid":false,"given":"Daniel","family":"Pleguezuelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-8255","authenticated-orcid":false,"given":"Estela","family":"Paz-Artal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"1174_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12728","volume":"287","author":"C Cunningham-Rundles","year":"2019","unstructured":"Cunningham-Rundles C. Common variable immune deficiency: Dissection of the variable. Immunol Rev. 2019;287:145\u201361. https:\/\/doi.org\/10.1111\/imr.12728.","journal-title":"Immunol Rev"},{"key":"1174_CR2","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","volume":"7","author":"MG Seidel","year":"2019","unstructured":"Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol Pract. 2019;7:1763\u201370. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.004.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1174_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2016;4:38\u201359. https:\/\/doi.org\/10.1016\/j.jaip.2015.07.025.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1174_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1081-1206(10)62149-7","volume":"90","author":"W Al-Herz","year":"2003","unstructured":"Al-Herz W, McGeady SJ. Antibody response in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2003;90:244\u20137. https:\/\/doi.org\/10.1016\/S1081-1206(10)62149-7.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1174_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","volume":"124","author":"S Goldacker","year":"2007","unstructured":"Goldacker S, Draeger R, Warnatz K, Huzly D, Salzer U, Thiel J, et al. Active vaccination in patients with common variable immunodeficiency (CVID). Clin Immunol. 2007;124:294\u2013303. https:\/\/doi.org\/10.1016\/j.clim.2007.04.011.","journal-title":"Clin Immunol"},{"key":"1174_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clim.2005.03.019","volume":"116","author":"J Ko","year":"2005","unstructured":"Ko J, Radigan L, Cunningham-Rundles C. Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol. 2005;116:37\u201341. https:\/\/doi.org\/10.1016\/j.clim.2005.03.019.","journal-title":"Clin Immunol"},{"key":"1174_CR7","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383:2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577.","journal-title":"N Engl J Med"},{"key":"1174_CR8","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","volume":"396","author":"MN Ramasamy","year":"2021","unstructured":"Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial. Lancet. 2021;396:1979\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(20)32466-1.","journal-title":"Lancet"},{"key":"1174_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:403\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2035389.","journal-title":"N Engl J Med"},{"key":"1174_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","volume":"595","author":"U Sahin","year":"2021","unstructured":"Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595:572\u20137. https:\/\/doi.org\/10.1038\/s41586-021-03653-6.","journal-title":"Nature"},{"key":"1174_CR11","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/s41467-017-01708-9","volume":"8","author":"MB Battles","year":"2017","unstructured":"Battles MB, Mas V, Olmedillas E, Cano O, Vazquez M, Rodriguez L, et al. Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein. Nat Commun. 2017;8:1528. https:\/\/doi.org\/10.1038\/s41467-017-01708-9.","journal-title":"Nat Commun"},{"key":"1174_CR12","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.abd0826","volume":"369","author":"CL Hsieh","year":"2020","unstructured":"Hsieh CL, Goldsmith JA, Schaub JM, DiVenere AM, Kuo HC, Javanmardi K, et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science. 2020;369:1501\u20135. https:\/\/doi.org\/10.1126\/science.abd0826.","journal-title":"Science"},{"key":"1174_CR13","doi-asserted-by":"crossref","unstructured":"Almendro-V\u00e1zquez PL-GR, RuizRuigomez M, Utrero-Rico A, Lalueza A, Maestro de la Calle G, Delgado P, Perez-Ordo\u00f1o L, Muro E, Vila J, Zamarron I, Moreno-Batanero M, Chivite-Lacaba, M, Gil-Etayo FJ, Lumbreras C, Arellano I, Alarcon B, Allende LM, Aguado JM, Paz-Artal E. Longitudinal dynamics of SARS-CoV-2-specific adaptive immunity after natural infection or BNT162b2 vaccination. Submitted and under review 2021.","DOI":"10.1371\/journal.ppat.1010211"},{"key":"1174_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2019.04.001","volume":"203","author":"C von Spee-Mayer","year":"2019","unstructured":"von Spee-Mayer C, Koemm V, Wehr C, Goldacker S, Kindle G, Bulashevska A, et al. Evaluating laboratory criteria for combined immunodeficiency in adult patients diagnosed with common variable immunodeficiency. Clin Immunol. 2019;203:59\u201362. https:\/\/doi.org\/10.1016\/j.clim.2019.04.001.","journal-title":"Clin Immunol"},{"key":"1174_CR15","doi-asserted-by":"publisher","first-page":"8390356","DOI":"10.1155\/2016\/8390356","volume":"2016","author":"F Pulvirenti","year":"2016","unstructured":"Pulvirenti F, Zuntini R, Milito C, Specchia F, Spadaro G, Danieli MG, et al. Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes. J Immunol Res. 2016;2016:8390356. https:\/\/doi.org\/10.1155\/2016\/8390356.","journal-title":"J Immunol Res"},{"key":"1174_CR16","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ng1600","volume":"37","author":"U Salzer","year":"2005","unstructured":"Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37:820\u20138. https:\/\/doi.org\/10.1038\/ng1600.","journal-title":"Nat Genet"},{"key":"1174_CR17","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35:1978\u201380. https:\/\/doi.org\/10.1093\/bioinformatics\/bty897.","journal-title":"Bioinformatics"},{"key":"1174_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7.","journal-title":"Nature"},{"issue":"1922\u201331","key":"1174_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.052","volume":"142","author":"A Gardulf","year":"2018","unstructured":"Gardulf A, Abolhassani H, Gustafson R, Eriksson LE, Hammarstrom L. Predictive markers for humoral influenza vaccine response in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2018;142(1922\u201331): e2. https:\/\/doi.org\/10.1016\/j.jaci.2018.02.052.","journal-title":"J Allergy Clin Immunol"},{"key":"1174_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.clim.2010.03.430","volume":"136","author":"S van Assen","year":"2010","unstructured":"van Assen S, Holvast A, Telgt DS, Benne CA, de Haan A, Westra J, et al. Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine. Clin Immunol. 2010;136:228\u201335. https:\/\/doi.org\/10.1016\/j.clim.2010.03.430.","journal-title":"Clin Immunol"},{"key":"1174_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11882-017-0749-3","volume":"17","author":"JF Mieves","year":"2017","unstructured":"Mieves JF, Wittke K, Freitag H, Volk HD, Scheibenbogen C, Hanitsch LG. Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID). Curr Allergy Asthma Rep. 2017;17:78. https:\/\/doi.org\/10.1007\/s11882-017-0749-3.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1174_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-3083.2011.02561.x","volume":"74","author":"G Pedersen","year":"2011","unstructured":"Pedersen G, Halstensen A, Sjursen H, Naess A, Kristoffersen EK, Cox RJ. Pandemic influenza vaccination elicits influenza-specific CD4+ Th1-cell responses in hypogammaglobulinaemic patients: four case reports. Scand J Immunol. 2011;74:210\u20138. https:\/\/doi.org\/10.1111\/j.1365-3083.2011.02561.x.","journal-title":"Scand J Immunol"},{"key":"1174_CR23","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.vaccine.2016.03.091","volume":"34","author":"LG Hanitsch","year":"2016","unstructured":"Hanitsch LG, Lobel M, Mieves JF, Bauer S, Babel N, Schweiger B, et al. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency. Vaccine. 2016;34:2417\u201323. https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.091.","journal-title":"Vaccine"},{"key":"1174_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5114\/ceji.2019.87060","volume":"44","author":"SB Erdem","year":"2019","unstructured":"Erdem SB, Gulez N, Genel F, Karaman S, Nacaroglu HT. Characteristics of the patients followed with the diagnosis of common variable immunodeficiency and the complications. Cent Eur J Immunol. 2019;44:119\u201326. https:\/\/doi.org\/10.5114\/ceji.2019.87060.","journal-title":"Cent Eur J Immunol"},{"key":"1174_CR25","first-page":"36","volume":"101","author":"M Schlumberger","year":"2008","unstructured":"Schlumberger M, Yvonnet B, Que HV, Chhem DB, Saliou P, Le Tu TC, et al. [Serological study carried out in Cambodia during a tetanus vaccination in adults]. Bull Soc Pathol Exot. 2008;101:36\u201342.","journal-title":"Bull Soc Pathol Exot"},{"key":"1174_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clim.2011.07.004","volume":"141","author":"S van Assen","year":"2011","unstructured":"van Assen S, de Haan A, Holvast A, Horst G, Gorter L, Westra J, et al. Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency. Clin Immunol. 2011;141:161\u20138. https:\/\/doi.org\/10.1016\/j.clim.2011.07.004.","journal-title":"Clin Immunol"},{"issue":"2332\u201340","key":"1174_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.04.019","volume":"8","author":"D Friedmann","year":"2020","unstructured":"Friedmann D, Goldacker S, Peter HH, Warnatz K. Preserved Cellular Immunity Upon Influenza Vaccination in Most Patients with Common Variable Immunodeficiency. J Allergy Clin Immunol Pract. 2020;8(2332\u201340): e5. https:\/\/doi.org\/10.1016\/j.jaip.2020.04.019.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1174_CR28","doi-asserted-by":"publisher","unstructured":"Squire J, Joshi A. Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency. Ann Allergy Asthma Immunol. 2021.https:\/\/doi.org\/10.1016\/j.anai.2021.05.015.","DOI":"10.1016\/j.anai.2021.05.015"},{"key":"1174_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.05.029","author":"D Hagin","year":"2021","unstructured":"Hagin D, Freund T, Navon M, Halperin T, Adir D, Marom R, et al. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity. J Allergy Clin Immunol. 2021. https:\/\/doi.org\/10.1016\/j.jaci.2021.05.029.","journal-title":"J Allergy Clin Immunol"},{"issue":"158\u201368","key":"1174_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine T, Perez-Potti A, Rivera-Ballesteros O, Stralin K, Gorin JB, Olsson A, et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020;183(158\u201368): e14. https:\/\/doi.org\/10.1016\/j.cell.2020.08.017.","journal-title":"Cell"},{"key":"1174_CR31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1473-3099(21)00059-1","volume":"21","author":"C Romero","year":"2021","unstructured":"Romero C, Diez JM, Gajardo R. Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products. Lancet Infect Dis. 2021;21:765\u20136. https:\/\/doi.org\/10.1016\/S1473-3099(21)00059-1.","journal-title":"Lancet Infect Dis"},{"key":"1174_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1182\/asheducation-2012.1.301","volume":"2012","author":"C Cunningham-Rundles","year":"2012","unstructured":"Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematology Am Soc Hematol Educ Program. 2012;2012:301\u20135. https:\/\/doi.org\/10.1182\/asheducation-2012.1.301.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1174_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1128\/CVI.00489-07","volume":"15","author":"N Rezaei","year":"2008","unstructured":"Rezaei N, Aghamohammadi A, Siadat SD, Moin M, Pourpak Z, Nejati M, et al. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency. Clin Vaccine Immunol. 2008;15:607\u201311. https:\/\/doi.org\/10.1128\/CVI.00489-07.","journal-title":"Clin Vaccine Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01174-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01174-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01174-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T16:42:02Z","timestamp":1644252122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-01174-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-01174-5","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"4 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethical Board (20\/167).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}